Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionMaverick Capital Ltd
Latest Disclosed Ownership1,377,738 shares
Latest Disclosed Value $ 80,060,355
Maverick Capital Ltd reports 1.74% increase in ownership of PCVX / Vaxcyte, Inc.

On May 15, 2026 - Maverick Capital Ltd filed a 13F-HR form disclosing ownership of 1,377,738 shares of Vaxcyte, Inc. (US:PCVX) valued at $80,060,355 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,354,237 shares of Vaxcyte, Inc.. This represents a change in shares of 1.74% during the quarter. The current value of the position is $64,657,244 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VAXCYTE COM 92243G108 1,377,738 23,501 1.74 80,060 28.13 0.9234
2026-02-13 2025-12-31 13F VAXCYTE COM 92243G108 1,354,237 64,670 5.01 62,484 34.52 0.6707
2025-11-14 2025-09-30 13F VAXCYTE COM 92243G108 1,289,567 -21,038 -1.61 46,450 9.02 0.6208
2025-08-14 2025-06-30 13F VAXCYTE COM 92243G108 1,310,605 102,512 8.49 42,608 -6.60 0.6398
2025-05-15 2025-03-31 13F VAXCYTE COM 92243G108 1,208,093 6,195 0.52 45,618 -53.64 0.8064
2025-02-14 2024-12-31 13F VAXCYTE COM 92243G108 1,201,898 225,649 23.11 98,387 -11.80 1.7704
2024-11-14 2024-09-30 13F VAXCYTE COM 92243G108 976,249 288,341 41.92 111,556 114.76 2.1751
2024-08-14 2024-06-30 13F VAXCYTE COM 92243G108 687,908 332,777 93.71 51,944 114.13 0.9852
2024-05-15 2024-03-31 13F VAXCYTE COM 92243G108 355,131 355,131 24,259 0.4559
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.